Skip to main content
. Author manuscript; available in PMC: 2015 Aug 1.
Published in final edited form as: Trends Cardiovasc Med. 2014 Jun 12;24(6):232–240. doi: 10.1016/j.tcm.2014.06.002

Figure 5.

Figure 5

5-year Kaplan-Meier Event Rate Estimates for the Primary Composite Endpoint in Diabetic Patients. Active-active vs. Placebo-placebo

Adapted with permission from

American Heart Journal:

“Lamas GA., Boineau R, Goertz C, Mark DB, Rosenberg Y, Stylianou M, et al. EDTA chelation therapy alone and in combination with oral high-dose multivitamins and minerals for coronary disease: The factorial group results of the Trial to Assess Chelation Therapy. Am Heart J [Internet]. Elsevier B.V.; 2014 Apr [cited 2014 Jun 5]; Available from: http://dx.doi.org/10.1016/j.ahj.2014.02.012